amercer said:
Maybe, maybe not. The other trials haven't read out yet so we don't know what the numbers will really be. It's been clear from the outset though that while the mRNA vaccines would be quicker to develop, that more traditional vaccines would have a huge advantage on the production side.
Can you explain the last point you made - regarding "production side".
I'm interested